Recent publications published by researchers at the MRC WIMM.
The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.
Journal article
Townsend A. et al, (2021), Nat Commun, 12
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.
Journal article
Frost JN. et al, (2021), Med, 2, 164 - 179.e12
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Journal article
Tan TK. et al, (2021), Nat Commun, 12
Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern
Journal article
Skelly D. et al, (2021)
Lung-targeting lentiviral vector for passive immunisation against influenza
Journal article
TAN TK. et al, (2020), Thorax
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Journal article
Rijal P. et al, (2020), J Virol, 94
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans
Journal article
RIJAL P. and TOWNSEND A., (2019), Journal of Virology
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.
Journal article
Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7
A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Journal article
Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
Journal article
Huang K-YA. et al, (2019), Nat Microbiol, 4, 306 - 315
Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells
Preprint
Barnkob M. et al, (2019)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Journal article
Saphire EO. et al, (2018), Cell, 174, 938 - 952.e13
Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.
Journal article
Beer K. et al, (2018), J Gen Virol, 99, 1001 - 1011
Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.
Journal article
Holzer B. et al, (2018), J Immunol, 200, 4068 - 4077
Structures of Ebola Virus Glycoprotein Complexes with Tricyclic Antidepressant and Antipsychotic Drugs.
Journal article
Zhao Y. et al, (2018), J Med Chem, 61, 4938 - 4945
Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.
Journal article
Tungatt K. et al, (2018), PLoS Pathog, 14
Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
Journal article
Xiao JH. et al, (2018), J Virol, 92